*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter - as a primary diagnosis code | T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.44 | |
| Readmission Rate (%) | 21.85 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 22 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter in DRG | 53.66 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 2.64 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $73,623 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $1,269 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $3,347 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $313,515 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $14,251 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 59.09 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 885: PSYCHOSES | DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,100,860 | ||||
| Total Hospitalizations with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 429 | ||||
| DRG Share of Total Hospitalizations | 3.35 | ||||
| % of Total ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter in DRG | 6.6 | ||||
| Avg LOS at DRG | 11.86 | ||||
| Avg LOS with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 16.63 | ||||
| Readmission Rate at DRG | 27.58 | ||||
| Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 33.58 | ||||
| Unplanned Readmission Rate at DRG | 13.34 | ||||
| Unplanned Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 13.73 | ||||
| Total Medicare payments at DRG | $9,312,828,663 | ||||
| Total Medicare payments with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $5,062,916 | ||||
| Total Medicare payment per Day at DRG | $713 | ||||
| Total Medicare payment per Day with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $710 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,460 | ||||
| Total Medicare payment per Hospitalization with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $11,802 | ||||
| Total Medicare Charges at DRG | $32,341,464,302 | ||||
| Total Medicare Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $23,203,529 | ||||
| Avg Charges at DRG | $29,378 | ||||
| Avg Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $54,087 | ||||
| Mortality Rate at DRG | 0.04 | ||||
| Mortality Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 5.83 | ||||
| SNF Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 7.69 | ||||
| Home Discharge Rate at DRG | 79.47 | ||||
| Home Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 69.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 164 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter in DRG | 2.52 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 3.66 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 17.61 | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 13.21 | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $789,497 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $1,314 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $4,814 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $4,788,569 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $29,199 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 17.07 | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 53.66 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 141 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter in DRG | 2.17 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 4.7 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 22.06 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 15.44 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $904,690 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $1,365 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $6,416 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $4,298,166 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $30,483 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 25.53 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 39.01 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 696: KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 149: DYSEQUILIBRIUM | DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 23,141 | ||||
| Total Hospitalizations with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 89 | ||||
| DRG Share of Total Hospitalizations | 0.07 | ||||
| % of Total ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter in DRG | 1.37 | ||||
| Avg LOS at DRG | 2.84 | ||||
| Avg LOS with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 3.4 | ||||
| Readmission Rate at DRG | 20.27 | ||||
| Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 19.32 | ||||
| Unplanned Readmission Rate at DRG | 15.25 | ||||
| Unplanned Readmission Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 14.77 | ||||
| Total Medicare payments at DRG | $96,280,494 | ||||
| Total Medicare payments with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $395,390 | ||||
| Total Medicare payment per Day at DRG | $1,467 | ||||
| Total Medicare payment per Day with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $1,305 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,161 | ||||
| Total Medicare payment per Hospitalization with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $4,443 | ||||
| Total Medicare Charges at DRG | $500,411,349 | ||||
| Total Medicare Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $1,943,355 | ||||
| Avg Charges at DRG | $21,624 | ||||
| Avg Charges with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | $21,835 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 15.28 | ||||
| SNF Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 25.84 | ||||
| Home Discharge Rate at DRG | 59.05 | ||||
| Home Discharge Rate with ICD T443X5A - Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter | 37.08 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| NORTH VISTA HOSPITAL | 1409 E LAKE MEAD BLVD | NORTH LAS VEGAS | NV | 89030 | 125 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 32 |
| NORTH SHORE MEDICAL CENTER | 81 HIGHLAND AVE | SALEM | MA | 01970 | 27 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. KEVIN BERNSTEIN | 7010 SMOKE RANCH RD STE 120 | LAS VEGAS | NV | 89128 | 110 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | E119 | Type 2 diabetes mellitus without complications |
| 2 | E039 | Hypothyroidism, unspecified |
| 3 | E785 | Hyperlipidemia, unspecified |
| 4 | K219 | Gastro-esophageal reflux disease without esophagitis |
| 5 | I10 | Essential (primary) hypertension |